Financial Enhancement »

Protagonist Therapeutics shares owned by Financial Enhancement

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Financial Enhancement from 13F filings

Historical chart of Financial Enhancement investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Financial Enhancement consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Financial Enhancement

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.1M 42k 25.40
2023-03-31 $1.1M 42k 25.40

More positions owned by Financial Enhancement

Spdr Series Trust State Street Spd (SPLG)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr S&p 100 Etf (OEF)
American Centy Etf Tr Intl Eqt Etf (AVDE)
Janus Detroit Str Tr Henderson Securi (JSI)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Janus Detroit Str Tr Henderson Mtg (JMBS)
Ishares Tr Msci Usa Min Vol (USMV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
First Tr Exchange-traded First Tr Enh New (FTSM)
Victory Portfolios Ii Shares Free Cash (VFLO)
First Tr Exchange-traded Lng Dur Oprtun (LGOV)
Janus Detroit Str Tr Hendrsn Shrt Etf (VNLA)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Invesco Exch Traded Fd Tr Ii S&p 500 Momntm (SPMO)

View all positions for Financial Enhancement

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics